Universidade Estadual de Londrina   Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4
Founded: Londrina Brazil (1970)

Organization Overview

First Clinical Trial
2003
NCT00317005
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Christiane Macedo | Universidade Estadual de Londrina

Active Ingredients

Drugs in Phase 4 Trials (2)

acetylcysteine (mucomyst) (3 trials)

folic acid (1 trial)

Drugs in Phase 3 Trials (1)

caffeine (1 trial)

Drugs in Phase 1 Trials (1)

diosmetine (1 trial)

Drugs in Other Trials (7)

budesonide (rhinocort) (1 trial)

clarithromycin (biaxin) (1 trial)

collagen (2 trials)

maltodextrin (1 trial)

menthol (Salonpas) (2 trials)

water (3 trials)

whey protein (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bipolar Disorder (Phase 4)

Cardiovascular Diseases (Phase 4)

Cellulitis (Phase 3)

Disease (Phase 4)

Hyperhomocysteinemia (Phase 4)

Inflammation (Phase 3)

Kidney Failure, Chronic (Phase 4)

Tobacco Use Disorder (Phase 4)

Uremia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 17
  • # of Trial APIs: 11